8 Best Life Sciences Penny Stocks to Buy
In this article, we will look at some of the best penny stocks in the life sciences sector that currently offer attractive upside potential for investors.
Standard Biotools Inc. (LAB)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Casdin Capital Eli Casdin | 88,783,856 | $73,042,478 | 3.66% | |
| 2. | Viking Global Andreas Halvorsen | 58,651,170 | $48,252,318 | 0.14% | |
| 3. | MAK Capital One Michael Kaufman | 28,813,904 | $23,705,199 | +11% | 3.32% |
| 4. | Long Focus Capital Management John B. Helmers | 23,500,000 | $19,333,450 | +47% | 0.49% |
| 5. | Royce & Associates Chuck Royce | 4,525,333 | $3,722,991 | +51% | 0.03% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $1.45 | 150,000 | $217,020.00 | 72,100,000 | 2025-12-04 | Filing | |
| $1.44 | 75,000 | $108,037.50 | 71,950,000 | 2025-12-03 | Filing | |
| $1.42 | 125,000 | $177,512.50 | 71,875,000 | 2025-12-02 | Filing | |
| $1.30 | 7,550,000 | $9,838,405.00 | 71,750,000 | 2025-11-25 | Filing | |
| $1.43 | 150,000 | $214,875.00 | 64,200,000 | 2025-11-24 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $0.94 | 1,428 | $1,343.75 | 930,286 | 2025-05-23 | Filing | |
| $0.94 | 13,217 | $12,437.20 | 843,076 | 2025-05-23 | Filing | |
| $0.94 | 5,473 | $5,150.09 | 2,741,191 | 2025-05-23 | Filing | |
| $1.00 | 1,355 | $1,357.71 | 931,714 | 2025-05-22 | Filing | |
| $1.00 | 5,116 | $5,126.23 | 2,746,664 | 2025-05-22 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 12,252,998 | $10,084,217 | 0% | |
| 2. | 8,254,443 | $6,790,930 | 0% | |
| 3. | 5,503,381 | $4,527,632 | 0.9% | |
| 4. | 4,958,620 | $4,039,205 | 0% | |
| 5. | 4,820,463 | $3,965,795 | 0% |
News See All
Standard BioTools Inc. (NASDAQ:LAB) Q1 2025 Earnings Call Transcript
Standard BioTools Inc. (NASDAQ:LAB) Q1 2025 Earnings Call Transcript May 6, 2025Standard BioTools Inc. misses on earnings expectations. Reported EPS is $-0.07 EPS, expectations were $-0.04.
Standard BioTools Inc. (NASDAQ:LAB) Q4 2024 Earnings Call Transcript
Standard BioTools Inc. (NASDAQ:LAB) Q4 2024 Earnings Call Transcript February 26, 2025Standard BioTools Inc. misses on earnings expectations. Reported EPS is $-0.09097 EPS, expectations were $-0.07.
Standard BioTools Inc. (NASDAQ:LAB) Q3 2024 Earnings Call Transcript
Standard BioTools Inc. (NASDAQ:LAB) Q3 2024 Earnings Call Transcript October 30, 2024Standard BioTools Inc. beats earnings expectations. Reported EPS is $-0.07, expectations were $-0.09.
7 Best NASDAQ Stocks Under $5
In this article, we discuss the 7 best NASDAQ stocks under $5 along with the latest updates around the market.
Standard BioTools Inc. (NASDAQ:LAB) Q2 2024 Earnings Call Transcript
Standard BioTools Inc. (NASDAQ:LAB) Q2 2024 Earnings Call Transcript July 31, 2024Standard BioTools Inc. misses on earnings expectations. Reported EPS is $-0.12279 EPS, expectations were $-0.06.
Standard BioTools Inc. (NASDAQ:LAB) Q1 2024 Earnings Call Transcript
Standard BioTools Inc. (NASDAQ:LAB) Q1 2024 Earnings Call Transcript May 11, 2024 Standard BioTools Inc.
Standard BioTools Inc. (NASDAQ:LAB) Q4 2023 Earnings Call Transcript
Standard BioTools Inc. (NASDAQ:LAB) Q4 2023 Earnings Call Transcript February 28, 2024 Standard BioTools Inc. beats earnings expectations. Reported EPS is $-0.08, expectations were $-0.13.
Standard BioTools Inc. (NASDAQ:LAB) Q3 2023 Earnings Call Transcript
Standard BioTools Inc. (NASDAQ:LAB) Q3 2023 Earnings Call Transcript November 7, 2023 Operator: Hello, and welcome to the Standard BioTools' Third Quarter 2023 Financial Results Conference Call.
Standard BioTools Inc. (NASDAQ:LAB) Q2 2023 Earnings Call Transcript
Standard BioTools Inc. (NASDAQ:LAB) Q2 2023 Earnings Call Transcript August 8, 2023 Standard BioTools Inc. misses on earnings expectations. Reported EPS is $-0.22 EPS, expectations were $-0.21.
Hedge Fund Resource Center